MD4410C1 - Soluţie balansată pentru infuzie - Google Patents

Soluţie balansată pentru infuzie

Info

Publication number
MD4410C1
MD4410C1 MDA20150042A MD20150042A MD4410C1 MD 4410 C1 MD4410 C1 MD 4410C1 MD A20150042 A MDA20150042 A MD A20150042A MD 20150042 A MD20150042 A MD 20150042A MD 4410 C1 MD4410 C1 MD 4410C1
Authority
MD
Moldova
Prior art keywords
infusion solution
balanced
sodium
balanced infusion
intoxications
Prior art date
Application number
MDA20150042A
Other languages
English (en)
Russian (ru)
Other versions
MD4410B1 (ro
MD20150042A2 (ro
Inventor
Алексей Леонидович Коваленко
Андрей Юрьевич Петров
Original Assignee
Ecopharm Patent Management Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecopharm Patent Management Ag filed Critical Ecopharm Patent Management Ag
Publication of MD20150042A2 publication Critical patent/MD20150042A2/ro
Publication of MD4410B1 publication Critical patent/MD4410B1/ro
Publication of MD4410C1 publication Critical patent/MD4410C1/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină şi farmacologie, şi anume la soluţii pentru infuzii saline, care posedă acţiune de dezintoxicare şi poate fi utilizată în tratarea bolilor şi stărilor asociate cu intoxicaţiile organismului de diferită gravitate.Esenţa invenţiei constă în aceea că soluţia balansată pentru infuzie conţine cloruri de sodiu, potasiu şi magneziu, L-arginin-succinat de sodiu şi apă, în următorul raport al componentelor, % mas.:
MDA20150042A 2014-05-20 2015-04-29 Soluţie balansată pentru infuzie MD4410C1 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014120144/15A RU2549448C1 (ru) 2014-05-20 2014-05-20 Сбалансированный инфузионный раствор

Publications (3)

Publication Number Publication Date
MD20150042A2 MD20150042A2 (ro) 2015-12-31
MD4410B1 MD4410B1 (ro) 2016-04-30
MD4410C1 true MD4410C1 (ro) 2016-11-30

Family

ID=53289744

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150042A MD4410C1 (ro) 2014-05-20 2015-04-29 Soluţie balansată pentru infuzie

Country Status (7)

Country Link
AR (1) AR099992A1 (ro)
EA (1) EA024426B1 (ro)
MD (1) MD4410C1 (ro)
NI (1) NI201500056A (ro)
PE (1) PE20151818A1 (ro)
RU (1) RU2549448C1 (ro)
UA (1) UA111116C2 (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2676761C1 (ru) * 2017-10-09 2019-01-11 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Полиионный инфузионный раствор

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA000879B1 (ru) * 1998-12-02 2000-06-26 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Инфузионный раствор "реамберин"
EA001099B1 (ru) * 1999-06-10 2000-10-30 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Инъекционное лекарственое средство "цитофлавин", обладающее цитопротекторным действием
EA007865B1 (ru) * 2005-03-01 2007-02-27 Общество С Ограниченной Ответственностью "Палисандр" Дезинтоксикационный инфузионный раствор

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1395327A1 (ru) * 1981-03-05 1988-05-15 Центральный научно-исследовательский институт гематологии и переливания крови Инфузионный раствор дл коррекции метаболического алкалоза "Сорбамин
SU1630043A1 (ru) * 1984-06-01 1994-02-28 Научно-исследовательский институт гематологии и переливания крови Плазмозамещающий раствор для лечения шока "мафусол"
RU2178296C1 (ru) * 2000-06-20 2002-01-20 Государственный научный центр лекарственных средств Инфузионный раствор для лечения заболеваний сердечно-сосудистой системы
RU2240116C1 (ru) * 2003-08-20 2004-11-20 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Дезинтоксикационный инфузионный раствор
WO2005032538A1 (ja) * 2003-10-03 2005-04-14 Ono Pharmaceutical Co., Ltd. (２ｒ)−２−プロピルオクタン酸を有効成分とする輸液製剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA000879B1 (ru) * 1998-12-02 2000-06-26 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Инфузионный раствор "реамберин"
EA001099B1 (ru) * 1999-06-10 2000-10-30 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Инъекционное лекарственое средство "цитофлавин", обладающее цитопротекторным действием
EA007865B1 (ru) * 2005-03-01 2007-02-27 Общество С Ограниченной Ответственностью "Палисандр" Дезинтоксикационный инфузионный раствор

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EA 001099 B1 30.10.2000 *
Реогемин. Регистрационное удостоверение Республики Беларусь РУ 12/12/2047 от 04.12.2012 *

Also Published As

Publication number Publication date
MD4410B1 (ro) 2016-04-30
NI201500056A (es) 2015-09-08
PE20151818A1 (es) 2016-01-09
MD20150042A2 (ro) 2015-12-31
AR099992A1 (es) 2016-08-31
RU2549448C1 (ru) 2015-04-27
EA201401164A1 (ru) 2015-11-30
EA024426B1 (ru) 2016-09-30
UA111116C2 (uk) 2016-03-25

Similar Documents

Publication Publication Date Title
MD20170020A2 (ro) Compoziţii şi metode utilizate pentru tratamentul tulburărilor metabolice
PH12017501674A1 (en) Amylin analogues
MX2015009444A (es) Trampas novedosas en el tratamiento de la degeneracion macular.
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
MX364220B (es) Metodos de tratamientos de fibrosis.
PH12017500747B1 (en) Heterocyclic compound
PH12016502415A1 (en) Treatment of severe hypertriglyceridemia
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EA201991175A1 (ru) Применение в медицине интерферона-лямбда для лечения фиброза
MX359029B (es) Procedimiento para el tratamiento de enfermedades relacionadas con el factor inducible por hipoxia (hif) -.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2019000677A (es) Células miméticas de células b.
MY181685A (en) Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
MX2016012758A (es) Composicion hiperosmolar de acido hialuronico.
MX2017007027A (es) Antagonista de a2a de dosis baja para el tratamiento de tdah y la enfermedad de parkinson.
MX364704B (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MD4410C1 (ro) Soluţie balansată pentru infuzie
MX2017009313A (es) Formulaciones intravenosas de baclofeno y metodos de tratamiento.
PH12017500084A1 (en) Vitamin b2 and its use
MX2018011512A (es) Uso de insulina para promover el vaciamiento gástrico.
IN2014MU01233A (ro)
MX2018004656A (es) Baclofeno intravenoso y metodos de tratamiento.
SG11201704161YA (en) Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
TN2016000064A1 (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees